11 min listen
Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more
FromVJHemOnc Podcast
Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more
FromVJHemOnc Podcast
ratings:
Length:
14 minutes
Released:
Dec 21, 2022
Format:
Podcast episode
Description
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,...
The post Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more appeared first on VJHemOnc.
The post Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more appeared first on VJHemOnc.
Released:
Dec 21, 2022
Format:
Podcast episode
Titles in the series (100)
Revolutionary immunotherapies for lymphoma: Immunotherapy has emerged in recent years as an effective novel treatment for lymphoma, with studies constantly striving to identify new... by VJHemOnc Podcast